BREAKING NEWS ~ Supreme Court says drug makers can ignore rival patents while researching generics

[JURIST] The US Supreme Court in a unanimous decision has ruled that drug companies can do "pre-clinical studies" under FDA rules on an existing patented drug in the process of developing a generic alternative to market in the future. Read a summary of Merck KGaA v. Integra Lifesciences [Duke Law backgrounder]. AP has more.

11:35 PM ET - The opinion is now available via Cornell LII.



 

About Paper Chase

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible format.

© Copyright JURIST Legal News and Research Services, Inc., 2013.